“The changing paradigm”: TAVR for low-risk patients approved by the FDA

Camilo A. Gomez, Joao Braghiroli, Eduardo de Marchena

Research output: Contribution to journalEditorialpeer-review

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)5-7
Number of pages3
JournalJournal of cardiac surgery
Volume35
Issue number1
DOIs
StatePublished - Jan 1 2020

Keywords

  • FDA
  • LOW RISK
  • SAVR
  • TAVR
  • TRIAL

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this